CVRx, Inc. balance sheet CVRX

Annual Quarterly

As of Sep 30, 2026, CVRx, Inc. had total assets of $87.6 million and total liabilities of $73.8 million. Total assets were down 21.3% from a year earlier. Stockholders' equity was $13.8 million. It held $58.7 million in cash and investments against $59.4 million of total debt, net debt of $639,000. The current ratio, current assets divided by current liabilities, was 6.80.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Assets
Cash
59
-31.0%
65
-32.0%
72
-29.6%
76
-28.5%
85
-15.0%
95
+35.0%
103
+28.2%
106
+17.0%
Cash and investments
59
-31.0%
65
-32.0%
72
-29.6%
76
-28.5%
85
-15.0%
95
+35.0%
103
+28.2%
106
+17.0%
Receivables
10
+16.8%
9
+31.4%
9
+1.0%
11
+15.1%
8
-9.1%
7
-16.9%
9
+6.1%
9
+21.9%
Inventory
14
+19.6%
13
+11.2%
12
+6.3%
12
+0.8%
11
-4.2%
12
+4.4%
12
+5.6%
12
+10.2%
Total current assets
85
-21.2%
89
-23.0%
97
-23.3%
102
-21.7%
108
-12.9%
116
+26.3%
126
+23.3%
130
+15.8%
Property and equipment, net
2
-20.7%
2
-12.1%
2
-11.3%
2
-10.5%
2
-7.0%
2
-15.1%
2
-4.5%
3
+42.1%
Total assets
88
-21.3%
92
-22.8%
100
-23.0%
105
-21.5%
111
-12.8%
120
+24.6%
130
+22.1%
133
+15.8%
Liabilities and equity
Accounts payable
4
+14.2%
4
+27.8%
3
+9.0%
4
+48.5%
4
+10.7%
3
-13.8%
3
+5.5%
3
+37.0%
Total current liabilities
13
+11.5%
11
+14.8%
9
+11.5%
13
+23.7%
11
+2.5%
10
+6.2%
9
+1.3%
11
+36.9%
Total liabilities
74
+16.6%
72
+17.4%
71
+17.3%
65
+5.0%
63
+1.2%
62
+51.3%
60
+50.9%
62
+58.7%
Stockholders' equity
14
-71.2%
20
-65.6%
29
-58.0%
39
-44.7%
48
-26.3%
58
+4.9%
69
+4.7%
71
-6.4%
Debt
Long-term debt
59
+18.6%
59
+18.6%
58
+18.6%
50
+0.5%
49
+0.5%
49
+68.5%
49
+68.5%
49
+68.6%
Lease liabilities
1
-31.9%
1
-28.9%
1
-17.1%
1
-14.6%
1
-12.6%
1
-9.3%
1
-18.0%
1
-16.7%
Total debt
59
+17.5%
59
+17.5%
59
+17.8%
51
+0.1%
51
+0.2%
51
+65.2%
50
+64.8%
50
+64.7%
Net cash
-1
-101.8%
5
-88.3%
13
-75.3%
25
-54.6%
35
-30.4%
44
+11.7%
52
+5.5%
56
-7.4%
Ratios
Current ratio
6.80x
8.04x
10.20x
7.63x
9.62x
11.99x
14.83x
12.06x
Debt to equity
4.30x
2.98x
2.04x
1.28x
1.05x
0.87x
0.73x
0.71x
Return on equity
-385.45%
-260.45%
-180.91%
-135.56%
-108.26%
-90.19%
-74.32%
-84.39%
Return on assets
-60.79%
-56.31%
-52.80%
-50.87%
-46.73%
-43.70%
-39.78%
-44.95%
Book value per share
0.49
0.75
1.10
1.49
1.83
2.22
2.66
2.81
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CVRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Minneapolis, MN
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1235912
Former names
CVRX INC (until Jul 15, 2013)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.